Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly

Neuropsychology

Volumn 27, Issue 4, 2013, Pages 391-401

  Salmon, David P ^a   Ferris, Steven H ^b   Thomas, Ronald G ^a,c   Sano, Mary ^d   Cummings, Jeffery L ^e   Sperling, Reisa A ^f   Petersen, Ronald C ^g   Aisen, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Cleveland Clinic Lou Ruvo Center for Brain Health   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MAYO CLINIC   (United States)

Author keywords

Aging; Apolipoprotein E; Cognitive decline

Indexed keywords

EID: 84887650863     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/a0032707     Document Type: Article

References (35)

1. Aisen, P. S., Andrieu, S., Sampario, C., Carillo, M., Khachaturian, Z. S., Dubois, B., Vellas, B. (2011). Report of the task force on designing clinical trials in early (pre-dementia) Alzheimer's disease. Neurology, 76, 280-286.
2. Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295-303.
3. Borkowski, J. G., Benton, A., & Spreen, O. (1967). Word fluency and brain damage. Neuropsychologia, 5, 135-140.
4. Bunce, D., Fratiglioni, L., Small, B. J., Winblad, B., & Backman, L. (2004). APOE and cognitive decline in preclinical Alzheimer's disease and non-demented aging. Neurology, 63, 816-821.
5. Butters, N., Granholm, E., Salmon, D. P., Grant, I., & Wolfe, J. (1987). Episodic and semantic memory: A comparison of amnesic and demented patients. Journal of Clinical and Experimental Neuropsychology, 9, 479-497.
6. Caselli, R. J., Dueck, A. C., Locke, D. E. C., Hoffman-Snyder, C. R., Woodruff, B. K., Rapcsak, S. Z., & Reiman, E. M. (2011). Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology, 76, 1383-1388.
7. Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Conner, D. J., Ahern, G. L.,... Reiman, E. M. (2009). Longitudinal modeling of age-related memory decline and the APOE ε4 effect. The New England Journal of Medicine, 361, 255-263.
8. Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., & Alexander, G. G. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE ε4 allele. Neurology, 62, 1990 -1995.
9. Ferris, S. H., Aisen, P. S., Cummings, J. L., Galasko, D., Salmon, D. P., Schneider, L., Thal, L. J. for the Alzheimer's Disease Cooperative Study Group. (2006). ADCS Prevention Instrument Project: Overview and initial results. Alzheimer Disease & Associated Disorders, 20, 109- 123.
10. Grober, E., Buschke, H., Crystal, H., Bang, S., & Dresner, R. (1988). Screening for dementia by memory testing. Neurology, 38, 900-903. doi:10.1212/WNL.38.6.900
11. Grober, E., & Kawas, C. (1997). Learning and retention in preclinical and early Alzheimer's disease. Psychology and Aging, 12, 183-188.
12. Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (1991). Revised comprehensive norms for an expanded Halstead-Reitan battery. Lutz, FL: Psychological Assessment Resources.
13. Hughes, C. P., Berg, L., Danzinger, W. L., Coben, L. A., & Martin, R. L. (1982). A new clinical scale for the staging of dementia. The British Journal of Psychiatry, 140, 566-572.
14. Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J. (1998). Association between apolipoprotein Eε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065-1069.
15. Kaplan, E., Goodglass, H., & Weintraub, S. (1983). Boston Naming Test. Philadelphia, PA: Lea & Febiger.
16. Kluger, A., Ferris, S. H., Golomb, J., Mittelman, M. S., & Reisberg, B. (1999). Neuropsychological prediction of decline to dementia in nondemented elderly. Journal of Geriatric Psychiatry and Neurology, 12, 168-179.
17. Laird, N. M., & Ware, J. H. (1982). Random-effects models for longitudinal data. Biometrics, 38, 963-974.
18. Mayeux, R., Small, S. A., Tang, M. X., Tycko, B., & Stern, Y. (2001). Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683- 689.
19. Mayeux, R., & Stern, Y. (2012). Epidemiology of Alzheimer's disease. In D. J. Selkoe, E. Mandelkow, & D. M. Holtzman (Eds.), The biology of Alzheimer disease (pp. 115-132). Cold Spring Harbor, NY: Cold Spring Harbor Press.
20. Mickes, L., Wixted, J. T., Fennema-Notestine, C., Galasko, D., Bondi, M. W., Thal, L. J., & Salmon, D. P. (2007). Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology, 21, 696-705.
21. Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., Thal, L. J. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer Disease Assessment Scale (ADAS) that broaden its scope. Alzheimer Disease & Associated Disorders, 11, 13-21.
22. Nilsson, L. G., Adolfsson, R., Backman, L., Cruts, M., Nyberg, L., Small, B. J., & van Broeckoven, C. (2006). The influence of APOE status on episodic and semantic memory: Data from a population-based study. Neuropsychology, 20, 645-657.
23. O'Hara, R., Yesavage, J. A., Kraemer, H. C., Mauricio, M., Friedman, L. F., & Murphy, G. M. (1998). The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society, 46, 1493-1498.
24. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303-308.
25. Reitan, R. (1958). Validity of the Trail-Making Test as an indicator of organic brain disease. Perceptual & Motor Skills, 8, 271-276.
26. Salmon, D. P., & Bondi, M. W. (2009). Neuropsychological assessment of dementia. Annual Review of Psychology, 60, 257-282.
27. Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., & Katzman, R. (2002). Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology, 59, 1022- 1028.
28. Small, B. J., Basun, H., & Backman, L. (1998). Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
29. Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M., Ives, D. G., Rapp, S. R., DeKosky, S. T. for the Ginko Evaluation of Memory (GEM) study. (2009). Ginkgo biloba for preventing cognitive decline in older adults. Journal of the American Medical Association, 302, 2663- 2670.
30. Teng, E. L., & Chui, H. C. (1987). The Modified Mini Mental State (3MS) Examination. Journal of Clinical Psychiatry, 48, 314-318.
31. United States War Department's Adjutant General's Office. (1944). Army Individual Test Battery: Manual of directions and scoring. (1944). Washington, DC: Author.
32. Walker, A. J., Batchelor, J., & Shores, A. (2009). Effects of education, and cultural background on performance on WAIS-III, WAIS-R and WMS-R measures: Systematic review. Australian Psychologist, 44, 216-223.
33. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corporation.
34. Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., Bennett, D. A. (2002). The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 1154-1160. .7.1154
35. Yaffe, K., Cauley, J., Sands, L., & Browner, W. (1997). Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 1110-1114.